Publications
- New possibilities in monitoring patients suffering from castration resistant prostate cancer by using circulating tumor cells2013 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Abiraterone acetate and quality of life of castration-resistant prostate cancer patients2013 | First Faculty of Medicine
- Circulating tumor cells as a source of information about castration-resistant prostate cancer2013 | First Faculty of Medicine
- Innovation in the treatment of castration – resistant prostate cancer2012 | First Faculty of Medicine
- Prognosis of T1G3 bladder cancer patients after the intravesical adjuvant bacillus Calmette-Gue´rin (BCG) immunotherapy.2012 | First Faculty of Medicine
- Are circulating tumor cells a future weapon in the fight against castration resistant prostate cancer?Publication without faculty affiliation
- Circulation tumor cells in castration resistant prostate cancerPublication without faculty affiliation
- Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?2024 | First Faculty of Medicine, Second Faculty of Medicine
- Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum2023 | First Faculty of Medicine, Second Faculty of Medicine
- Serum Thymidine Kinase 1 - Potential Prostate Cancer Biomarker: A Clinical Study2023 | First Faculty of Medicine, Second Faculty of Medicine
Loading network view...